Clinical Trial

Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.

Name: Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease. — clinical trial record (NCT07105956)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium \[68Ga\]-DOTA-HK-011 in neuroinflammation imaging of Alzheimer's disease.

Trial Details

NCT Number	NCT07105956
Lead Sponsor	Nanjing First Hospital, Nanjing Medical University
Conditions	Alzheimer's Disease (AD)
Enrollment	8 participants
Start Date	2025-09-01
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-06